CTRI/2023/02/050014尚未招募2 期
An Experimental controlled clinical study to find the efficacy of Bhadradi kashaya administered orally and as Kala basti in the management of Sthulapramehi (Diabesity)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. BMI - >25-35
- •2.FBS â?? >126-300mg/dl
- •PPBS - >200-380mg/dl
- •3.HbA1c- >6.5-12
- •(Patient having classical symptom of sthula and prameha as per ayurvedic
- •4.Waist-hip ratio-
- •Male - > 1
- •Female >0.86
- •5. Waist circumference-
- •Male - > 102 cm
- •Female- > 80cm
- •6.HbA1c- <5.7( for sthula individual)
排除标准
- •1. Patients unfit for Basti Karma.
- •2. Chronicity: More than 5yrs.
- •3. Severe systemic diseases like- Pulmonary tuberculosis. Gestational
- •diabetes and malignancy
- •4. Patients with T2 DM exceeding the following plasma glucose limits-
- •a) Fasting plasma glucose values of >= 300mg/dL
- •b) RBS,PPBS>= 380mg/dL
- •5. Juvenile Diabetes
- •6. Insulin dependent Diabetes mellitus
- •7. Individuals with co-morbidity like HTN (sthula individual)
研究者
相似试验
已完成
不适用
Evaluation of the safety and initial performance of the REPAIR Bone Putty in the treatment of patients with tibia fracturesMusculoskeletal DiseasesOpen tibia fracturesPACTR201510001305535Carmell Therapeutics Corp.30
尚未招募
2 期
To assess the efficacy of Suvarnaprashan yoga and Samangadi leha 0n growth and development in InfantsCTRI/2024/06/068844RGGPG Ayurvedic College
进行中（未招募）
不适用
Optimized TacrolimuS and MMF for HLA Antibodies (proteins that are sometimes produced by the immune system) after Renal TransplantatioRenal Transplant recipients with HLA antibodies, who are at increased risk of graft dysfunction and graft failureMedDRA version: 14.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000004865EUCTR2012-004308-36-GBKings College London
尚未招募
3 期
Study to check the effect of ayurvedic nasal drop in greying of hair in youngstersCTRI/2024/02/062459CCRAS Ministry of AYUSH GOI
已完成
不适用
Yoga and quality of life studyCancerISRCTN61120944niversity of Derby (UK)54